Skip to main content
Premium Trial:

Request an Annual Quote

Clemson Uses $4M in Private, State Funds for Human Genetics Chair

NEW YORK (GenomeWeb News) – Clemson University will use $4 million in private and state funding to create a new chair in genetics research at its Center for Human Genetics, and it will select a "leading geneticist" to hold the chair, Clemson said on Tuesday.

Clemson will use funding from the Self Family Foundation and the state of South Carolina to create the Self Family Endowed Chair in Human Genetics, a program that will create a research and development team that will study prevention, diagnostic, and treatment-related questions.

The university said the endowed chair also will enable it to expand upon the research capabilities of the Greenwood Genetic Center's J.C. Self Institute, including studies of disorders that are prevalent in South Carolina, such as diabetes, cancer, and cardiovascular disease.

Clemson said in June that it plans to build a 17,000 square-foot center that will be an expansion of the Self Institute in Greenwood, about 60 miles from Clemson.

The Self Family chair will be a component of Clemson's College of Agriculture, Forestry, and Life Science.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.